JOURNALS CANCER RESEARCH 2012 · 2012-03-06 · cancer research or clinical management. Breast Disease now also publishes unsolicited peer-reviewed articles. Topics can cover basic

www.iospress.com

JOURNALS

CANCER

RESEARCH2012

I O S P R E S S J O U R N A L P R O G R A M

All IOS Press journals are published online and in print

Visit www.iospress.com to:

• Enter your subscription online• Check all subscription options including backfiles• Purchase articles on a pay-per-view basis• Obtain a free electronic sample copy• Scan tables of contents• Set up a journal alert• Find complete Instructions for Authors

Open Library®: Open Access at IOS Press

In addition to publishing work in traditional subscription journals, IOS Press offers the option to publish research with open access, i.e. free to

use, download, circulate, and disseminate by everyone, wherever in the world, as long as

proper attribution is given to the author and theoriginal source. The Open Library® option is available to all authors and for all journals

published by IOS Press.

IOS PRESS EBOOKS PROGRAM

www.booksonline.iospress.com

• Place your order online for ebooks or hardcopy books

• Browse tables of contents• Read abstracts and preliminary pages free

of charge• Search by subject or book series• Buy single titles and gain immediate access• Become a member and gain full access to all titles

JOURNALS

Analytical Cellular Pathology

Impact Factor: 4.169*Calculated based on Cellular Oncology articles published in 2007-2008

ISSN 2210-7177 (print)ISSN 2210-7185 (online)

Analytical Cellular Pathology focuses on the burgeoningapplications of physical techniques to the study of cells,tissues and organs in disease to elucidate pathogenesis andfurther translational research, enhanced diagnosis or prognostication, as well as new and better therapies. Of particular relevance are studies that explore the ways thataberrant biochemical and molecular pathways are transducedinto the physical processes that underlie pathogenesis.

The journal appeals to an audience of pathologists, cell biologists and biochemists, as well as biomedical engineersby focusing on new applications of the rapidly evolving array of technologies. Papers should be based on novel concepts, novel methodologiesor the novel use of existing methodologies that contribute to the study ofpathologic processes, rather than methodological details only. Approaches include tools such as biomedical photonics, surface resonance phenomena andimpedance tomography, as well as new approaches for ultra-high resolution magnetic resonance, multispectral, hyperspectral and vibrational mode analysis and computational biology models. Hypothesis generating and hypothesis-testing observational studies are also welcome.

Editor-in-ChiefStanley Cohen, MD, University of Medicine & Dentistry of New Jersey, New Jersey Medical School, Newark, NJ, USA Email: [email protected]

Coordinating Editor Marion C. Cohen, PhD, SUNY Downstate Medical Center, Brooklyn, NY, USAEmail: [email protected]

Associate Editors Ulysses J. Balis, USA Richard Levenson, USAElaine Bearer, USA Jonathan Reichner, USAHilary Coller, USA Thomas Ried, USAWalter Giaretti, Italy Gordon W. Stamp, United KingdomRonald H. Goldfarb, USA Ronald S. Weinstein, USA

Abstracting & Indexing CoverageAcademic Source Complete, Biochemistry & Biophysics Citation Index, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical AbstractsService (CAS), Current Contents/Clinical Medicine, Current Contents®/ LifeSciences, EBSCO Databases, Elsevier BIOBASE, Embase, Global Health,Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity,PubMed, Science Citation Index Expanded (SciSearch®), Science CitationIndex® (*Wos), SciVerse Scopus, SIIC Data Bases, Ulrich’s Periodicals Directory

Instructions for Authorswww.iospress.com/journal/analytical-cellular-pathology

Subscription Information 2012Volumes 34-35 (12 issues)Institutional subscription (print & online): US$2120 / €1504 (including postage & handling)Institutional subscription (online only): US$1955 / €1390 Individual subscription (online only): US$300 / €250

Brief History Analytical CellularPathology waslaunched in 1988,changed its name to Cellular Oncologybetween 2005 and2009 and then in2010, reverted to Analytical CellularPathology: CellularOncology. In 2011 itcontinues as AnalyticalCellular Pathology.

*Journal Impact Factors fromJournal Citation Reports®

Science Edition 2009, publishedby Thomson Reuters ©2010

Breast DiseaseAn International Journal


The recent expansion of work in the field of breast cancerinevitably will hasten discoveries that will impact patientoutcome. This research, that spans basic science, clinicalmedicine, epidemiology and public policy, poses difficultiesfor investigators. Not only is it necessary to be facile incomprehending ideas from many disciplines, but also, it isimportant to understand the public implications of these discoveries.

Breast Disease publishes review issues devoted to in-depth analyses of the scientific and public implicationsof recent research on a specific problem in breast cancer.Meeting the information needs of scientists, cliniciansand policy makers, the reviews not only discuss recentdiscoveries, but also reflect on their impact in breastcancer research or clinical management.

Breast Disease now also publishes unsolicitedpeer-reviewed articles. Topics can cover basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging and social and legal issues.

Editor-in-ChiefJeffrey E. Green, MD, Bethesda, MD, USA Email: [email protected]

Founding EditorEdison T. Liu, MD, Executive Director, Genome Institute of Singapore

Abstracting & Indexing CoverageAcademic Source Complete, Cancer Prevention and Control Database,Chemical Abstracts Service (CAS), EBSCO Databases, ElsevierBIOBASE, Embase, Epilepsy Education and Prevention Database, Health Education and Promotion Database, Index Medicus, MEDLINE,Prenatal Smoking Cessation Database, PubMed, SciVerse Scopus, Ulrich’s Periodicals Directory

Instructions for Authorswww.iospress.com/journal/breast-disease

Subscription Information 2012Volume 34 (4 issues)Institutional subscription (print & online): US$646 / €460 (including postage & handling)Institutional subscription (online only): US$590 / €420Individual subscription (online only): US$175 / €150

Cancer Biomarkers

Impact Factor: 2.418*


Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associatedwith the disease processes, whether or not they are anintegral part of the pathological lesion. The diseasemarkers may include, but are not limited to, genomic,epigenomic, proteomics, cellular and morphologic andgenetic factors predisposing to the disease or indicatingthe occurrence of the disease. Manuscripts on thesefactors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation, are accepted.

Editor-in-ChiefSudhir Srivastava, PhD, MPH, National Cancer Institute, NIH,Bethesda, MD, USAEmail: [email protected]

Associate EditorsWilliam E. Grizzle, MD, PhDAnna Lokshin, PhDAttila T. Lorincz, PhD Paola Muti, MD Harvey Pass, MD Tesshi Yamada, MD, PhD

Abstracting & Indexing CoverageAcademic Source Complete, Biological Abstracts, BIOSIS Previews,CAB Abstracts, Chemical Abstracts Service (CAS), ElsevierBIOBASE, Embase, EMBIO, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubsHub, Science Citation Index Expanded (SciSearch®), SciVerse Scopus, Ulrich’sPeriodicals Directory

Instructions for Authorswww.iospress.com/journal/cancer-biomarkers




Disease Markers

Impact Factor: 1.723*


Disease Markers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identificationof markers associated with the disease processes, whetheror not they are an integral part of the pathological lesion.The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or withabnormal tissue distribution. This journal is designed toprovide a forum for publications dealing with original observations in this developing field on any aspect of thegeneral topic including:

• Identification of new genetic or non-genetic markers(e.g., cell-surface antigens, serum proteins, intra- andextra-cellular enzymes, cytogenic markers and DNA-sequences)

• Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states

• Amplification of knowledge about existing markers • Family studies of markers in disease • New techniques for identification and/or isolation of important marker

molecules • Use of monoclonal antibodies for the definition of molecular structures

associated with disease markers • Identification of disease-associated abnormalities in DNA using

recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms

• Identification of markers identifying malignantly transformed neoplastic cells

Editor-in-ChiefSudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USAEmail: [email protected]

Associate EditorMichele Carbone, MD, PhD

Abstracting & Indexing CoverageAcademic Source Complete, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, CAB Abstracts, Chemical Abstracts Service(CAS), CSA Illumina, EBSCO Databases, Elsevier BIOBASE, Embase, EMBIO,Global Health, Index Copernicus, Journal Citation Reports/Science Edition,MEDLINE, Prous Science Integrity, PubMed, Reference Update®, Science Citation Index Expanded (SciSearch®), SciVerse Scopus, Ulrich’s PeriodicalsDirectory

Instructions for Authorswww.iospress.com/journal/disease-markers




Human Antibodies

ISSN 1093-2607 (print)ISSN 1875-869X (online)

Human Antibodies is an international journal designedto bring together all aspects of human hybridomas andantibody technology under a single, cohesive theme.This includes fundamental research, applied scienceand clinical applications. Emphasis is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization,defined antigens, tissue reactivity, scale-up production,chimeric antibodies, autoimmunity, naturalantibodies/immune response, anti-idiotypes and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, are also featured.

Editor-in-ChiefMark C. Glassy, PhD, Integrated Medical Sciences Association Foundation, San Diego, CA, USAEmail: [email protected]

Abstracting & Indexing CoverageAcademic Source, Article@inist, Biological Abstracts, BIOSIS Previews, Cambridge Scientific Abstracts, Chemical Abstracts Service(CAS), CSA Illumina, EBSCO Databases, Embase, Index Medicus,MEDLINE, PubMed, SciVerse Scopus, SUBIS, Ulrich’s Periodicals Directory

Instructions for Authorswww.iospress.com/journal/human-antibodies

Subscription Information 2012Volume 21 (4 issues)Institutional subscription (print & online): US$796 / €570 (includingpostage & handling)Institutional subscription (online only): US$740 / €530 Individual subscription (online only): US$185 / €155

Also of interest

Translational Pathology of Early Cancer

Editors: S. Srivastava and W.E. GrizzleMarch 2012, 568 pp., hardcoverISBN 978-1-61499-023-9 (print)ISBN 978-1-61499-024-6 (online)Price: US$239 / €156

The visual pathologic features of tumors have always been the critical parameters in determining tumortype, however, over the last several decades molecularanalysis of tumors has played an increasing role in the diagnostic pathology of tumors. Thus, “molecular pathology”has gradually emerged as a discipline in pathology whichexploits the use of nucleic acid based techniques.

The purpose of this Handbook is to discuss the principlesand the application of selected existing methods of molecular pathology and its use in the detection of early cancer. It describes the molecular changes thatcharacterize preinvasive neoplastic lesions, moleculartargets for early detection, validation of molecular targets and areas of new diagnostic technology that showpromise either for early detection of neoplasias or other medically important uses in cancer prevention and care. The book describes recent advances in proteomics,metabolomics, stem cells research, micro RNA and other posttranslational molecularmodifications; all these will serve the pressing needs in the development of the practice of personalized medicine.

The book is divided into three sections that follow a sequence from basic mechanismsof tumor development, through the molecular and biological abnormalities found incommon types of cancers, to the technologies that are most applicable to detectingthese biologic alterations in precancerous lesions. Each chapter discusses the scientificunderpinnings of the evolution and progression of tumors in order to enable cliniciansand other professionals who manage cancer patients to better understand the diseaseat the molecular and genetic levels.

Follow us on Twitter: @IOSPress_STM

PUBLISH YOUR RESEARCH RESULTS OR CONFERENCE PROCEEDINGS WITH IOS PRESS

IOS Press welcomes proposals for publishing textbooks, edited volumes, handbooks, conference proceedings, monographs anddissertations.

Proposals can be sent to [email protected], or you can fill inthe form in the Authors’ Corner on www.iospress.com.

Why publish with IOS Press?

High visibility of the publication· Book is submitted to relevant scientific indexes· Inclusion in Google Book Search

Lenient copyright policy· Authors retain copyright to their articles· Manuscript versions may be posted freely on personal websites

Print and online publication· DOI registration for all articles· All book articles available as separately downloadable items· High quality print publication produced in the Netherlands

Clear guidelines for authors and editors· Guidelines can be found through the Authors’ Corner

on www.iospress.com · Author templates for LaTeX or MSWord at author’s choice

Personal approach· Dedicated team of skilled publishing professionals· All books receive individual attention· Flexibility

Worldwide marketing and distribution· Books are available through all major booksellers including

Amazon and Barnes & Noble· Sales offices and representatives on all continents

Permanent archiving is guaranteed through an arrangementwith the Dutch Royal Library

To explore IOS Press books and the Authors’ Corner, visit www.iospress.com.

For ebooks, go to www.booksonline.iospress.com

ABOUT IOS PRESS

For over 20 years IOS Press has been serving the scientificcommunity worldwide. IOS Press publishes about 120 newbooks and 100 international journals each year coveringtopics ranging from computer science and mathematics tomedicine and the natural sciences.

All titles in this catalogue are available online as well as in print. Many titles are covered in the most important abstracting databases, such as Thomson Reuters / ISI,MEDLINE and SciVerse Scopus.

Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press has established several strategic co-publishing initiatives. Notable acquisitions included Delft University Press in2005 and Millpress Science Publishers in 2008.

IOS Press journals are available throughthe highly-regarded MetaPress platform(http://iospress.metapress.com).

Order Online at www.iospress.com Select the title of your choice and click subscribe now. No shipping costs will be charged.

Yes, I would like to order…� Please send me the following journals: ________________________________________

______________________________________________________________________

______________________________________________________________________

� Please send me the following book: Translational Pathology of Early Cancer

� Please bill me (postage and handling charges will be added)

� Please charge my credit card: � American Express � Euro/MasterCard � Visa

Card #: __________________________________________________________________________

Security Code: ______________________________________________ Exp. Date: ____________

VAT #: __________________________________________________________________________

Name: __________________________________________________________________________

Address: ________________________________________________________________________

City/State: ____________________________ Zip/Postal Code: ________Country: ____________

Email: ________________________________________Fax: ______________________________

Signature: ______________________________________Date: ____________________________

2/12

Order from your local bookseller or usual supplier.

If you would like to order directly from IOS Press, please use one of the addresses below:

ORDER FORM

IOS Press, Inc.4502 Rachael Manor DriveFairfax, VA 22032USATel: +1 703 323 5600Fax: +1 703 323 [email protected](Books only)

IOS PressNieuwe Hemweg 6B1013 BG AmsterdamThe NetherlandsTel: +31 20 688 3355Fax: +31 20 687 0019Email: [email protected]

IOS Pressc/o Accucoms US, Inc.For North America Sales and Customer Service (Journals only)West Point Commons, Suite 201Lansdale, PA 19446USATel: +1 866 855 8967Fax: +1 215 660 5042Email: [email protected]

www.iospress.com

Documents

JOURNALS CANCER RESEARCH 2012 · 2012-03-06 · cancer research or clinical management. Breast Disease now also publishes unsolicited peer-reviewed articles. Topics can cover basic